Reata Pharmaceuticals is an IPO Standout

Reata Pharmaceuticals is an IPO Standout

By Agency Creative
June 30th, 2016

Reata Pharmaceuticals —one of Agency Creative’s longest-standing clients— is a superstar in this spring’s humdrum IPO market.

The pace of initial public offerings may have slowed in the first four months of 2016, but Reata Pharmaceuticals took off like a rocket.

When the IPO closed on June 1, Reata Pharmaceuticals President and CEO Warren Huff and his team had sold more than 6.3 million shares—and the price had reached a high of nearly $20.

Agency Creative has been Reata’s marketing partner since 2002—an exciting journey that’s included comprehensive branding, evolving website versions, digital marketing, advertising and more.

“It’s a thrill to celebrate with Warren and the whole Reata team as they continue to improve care with innovative treatments for pulmonary hypertension, melanoma and other significant diseases,” said Mark Wyatt, founder and CEO of Agency Creative. “We’re privileged to have such a long, mutually beneficial relationship with Reata.”

Reata Pharmaceuticals IPO

Reata Pharmaceuticals —one of Agency Creative’s longest-standing clients— is a superstar in this spring’s humdrum IPO market.

The pace of initial public offerings may have slowed in the first four months of 2016, but Reata Pharmaceuticals took off like a rocket.

When the IPO closed on June 1, Reata Pharmaceuticals President and CEO Warren Huff and his team had sold more than 6.3 million shares—and the price had reached a high of nearly $20.

Agency Creative has been Reata’s marketing partner since 2002—an exciting journey that’s included comprehensive branding, evolving website versions, digital marketing, advertising and more.

“It’s a thrill to celebrate with Warren and the whole Reata team as they continue to improve care with innovative treatments for pulmonary hypertension, melanoma and other significant diseases,” said Mark Wyatt, founder and CEO of Agency Creative. “We’re privileged to have such a long, mutually beneficial relationship with Reata.”


Recommend this article:

Reata Pharmaceuticals —one of Agency Creative’s longest-standing clients— is a superstar in this spring’s humdrum IPO market.

The pace of initial public offerings may have slowed in the first four months of 2016, but Reata Pharmaceuticals took off like a rocket.

When the IPO closed on June 1, Reata Pharmaceuticals President and CEO Warren Huff and his team had sold more than 6.3 million shares—and the price had reached a high of nearly $20.

Agency Creative has been Reata’s marketing partner since 2002—an exciting journey that’s included comprehensive branding, evolving website versions, digital marketing, advertising and more.

“It’s a thrill to celebrate with Warren and the whole Reata team as they continue to improve care with innovative treatments for pulmonary hypertension, melanoma and other significant diseases,” said Mark Wyatt, founder and CEO of Agency Creative. “We’re privileged to have such a long, mutually beneficial relationship with Reata.”

News

Agency Creative Hires Bart Hirneise as Executive Creative Director

A Partnership Thirteen Years in the Making

Posted on:

Thirteen years ago, an up-and-coming copywriter named Bart Hirneise was freelancing at Agency Creative. Recently on the market and looking for his next opportunity, Bart liked the vibe of the agency, the clients and, in particular, the CEO, Mark Wyatt. The two quickly formed a bond around their straightforward, no-bull approach to producing great creative.

Read More »

Blog

Leveraging Hype to Boost Brand Marketing

Updated on:

What is it we hear from clients constantly? “We want this to go viral.” While there is no silver bullet for making something go viral, you can, however, get the next best thing.
Read More »

Contact Us

Agency Creative wants to be your marketing agency. We have years of experience, truckloads of talent and a bottomless supply of enthusiasm. Contact us today.